Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma
Drug Delivery and Translational Research · 2024-11 · 14 (11) · 3212-3224
DOI: 10.1007/s13346-024-01543-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 26.02.2024. Verfasst von Furqan A Maulvi und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, 2052, Australia. Hauptthemen laut MEDLINE: Timolol, Chitosan, Glaucoma, Nanoparticles. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
To improve drug bioavailability, eye drops can be replaced by drug-eluting contact lenses. However, issues of drug leaching from lenses during manufacture and storage, and sterilization, currently limit their commercial application. To address the issues, stimuli-(lysozyme)-sensitive chitosan nanoparticles were developed to provide controlled ocular drug delivery. Nanoparticles were prepared by ionic gelation and characterized by TEM, X-ray diffraction, DSC, and FTIR. In the flux study, conventional-soaked contact lenses (SM-TM-CL) showed high-burst release, while with direct drug-only laden contact lenses (DL-TM-CL) the drug was lost during extraction and sterilization, as well as having poor swelling and optical properties. The nanoparticle-laden contact lenses (TM-Cht-NPs) showed controlled release of timolol for 120 h in the presence of lysozyme, with acceptable opto-physical properties. In the shelf-life study, the TM-Cht-NPs contact lenses showed no leaching or alteration in the drug release pattern. In animal studies, the TM-NPs-CL lenses gave a high drug concentration in rabbit tear fluid (mean = 11.01 µg/mL for 56 h) and helped maintain a low intraocular pressure for 120 h. In conclusion, the chitosan nanoparticle-laden contact lenses demonstrated the potential application to treat glaucoma with acceptable opto-physical properties and addressed the issues of drug-leaching during sterilization and storage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, 2052, Australia.
- Maliba Pharmacy College, Uka Tarsadia University, Surat, 394350, India.
- Maliba Pharmacy College, Uka Tarsadia University, Surat, 394350, India. ditixa.desai@gmail.com.
- Department of Chemical Engineering and Department of Anesthesiology, University of Florida, Gainesville, FL, 32611, USA.
ORCID-Profile: Ditixa T Desai
Zitieren
APA
Maulvi, F. A., Patel, A. R., Shetty, K. H., Desai, D. T., Shah, D. O., & Willcox, M. D. P. (2024). Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma. Drug Delivery and Translational Research, 14(11), 3212-3224. https://doi.org/10.1007/s13346-024-01543-8
Vancouver
Maulvi FA, Patel AR, Shetty KH, Desai DT, Shah DO, Willcox MDP. Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma. Drug Delivery and Translational Research. 2024;14(11):3212-3224. doi:10.1007/s13346-024-01543-8
BibTeX
@article{Maulvi2024,
author = {Maulvi, Furqan A and Patel, Ashmi R and Shetty, Kiran H and Desai, Ditixa T and Shah, Dinesh O and Willcox, Mark D P},
title = {Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma},
journal = {Drug Delivery and Translational Research},
year = {2024},
volume = {14},
number = {11},
pages = {3212--3224},
doi = {10.1007/s13346-024-01543-8}
}
EUVIMED